Difelikefalin Acetate is an analgesic opioid peptide indicated for the treatment of moderate to severe pruritus associated with chronic kidney disease. It functions by binding to opioid receptors to inhibit… Read more














Difelikefalin Acetate is an analgesic opioid peptide indicated for the treatment of moderate to severe pruritus associated with chronic kidney disease. It functions by binding to opioid receptors to inhibit pain and itch signaling pathways. Pharmaceutical laboratories require specialized materials for rigorous analytical testing and quality control of this therapeutic agent. This category provides essential Difelikefalin Acetate reference standards, including degradation impurities, metabolites, and stable isotope labelled compounds. These materials are critical for accurate impurity profiling and the development of robust analytical methods. By utilizing these precise standards, scientists can reliably identify degradation products and perform method validation throughout the drug development process. These products are designed to support the characterization and compliance requirements necessary for ensuring the consistency and quality of the parent drug in a controlled laboratory environment.